<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04172649</url>
  </required_header>
  <id_info>
    <org_study_id>AcuPro 09.2019</org_study_id>
    <secondary_id>DRK S00019884</secondary_id>
    <nct_id>NCT04172649</nct_id>
  </id_info>
  <brief_title>Acupuncture With Press Tack Needles for Perioperative Pain After Open Radical Prostatectomy</brief_title>
  <acronym>AcuPro</acronym>
  <official_title>A Randomized Controlled Study on Acupuncture for Perioperative Pain After Open Radical Prostatectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Martini-Klinik am UKE GmbH</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Seirin Corporation, Shizuoka City, Japan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Martini-Klinik am UKE GmbH</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acupuncture has been shown in several meta-analyses and clinical studies, in different
      surgical settings and chronic back pain, to be a safe adjuvant option for postoperative pain
      treatment. In this study, the investigator hypothesize that acupuncture can decrease
      postoperative pain intensity and amount of given analgesics, and accelerate recovery of bowel
      motility, in patients after open radical prostatectomy.

      The investigator will also investigate whether or not acupuncture with needle skin
      penetration is more efficacious than acupressure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will be a randomized, controlled and partially blinded study with three arms: 1)
      press tack needle acupuncture (ACU) and routine postoperative analgesic care, 2) press tack
      placebo acupressure (SHAM) and routine postoperative analgesic care, and 3) only routine
      postoperative analgesic care (CONTROL).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2020</start_date>
  <completion_date type="Anticipated">August 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative pain intensity measured by Numeric Rating Scale (NRS-11)</measure>
    <time_frame>postoperative day three</time_frame>
    <description>The primary outcome is to check the effects of permanent needle acupuncture at 6 acupuncture points for changing postoperative pain intensity as measured by the Numeric Rating Scale (NRS-11), calculated as area under the curve (AUC).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cumulative use (sum in mg) of routine postoperative analgesics</measure>
    <time_frame>postoperative day three</time_frame>
    <description>Cumulative use (sum in mg) of routine postoperative analgesics</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first defecation following surgery</measure>
    <time_frame>postoperative day three</time_frame>
    <description>Time to first defecation following surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EQ-5D-5L for quality of life</measure>
    <time_frame>7 days after catheter removal</time_frame>
    <description>fill out a questionnaire: According to the website httpp://euroqol.org/eq-5d-instruments/eq-5d-5l-about/ under the tab &quot;User guide 5L&quot;, page 5 in a blue box, it states that EQ-5D-5L is not an abbreviation and should be used and quoted as is. The EQ-5D-5L questionnaire measures quality of life based on 5 different levels (no problems, slight problems, moderate problems, severe problems and extreme problems) to each of the following dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">126</enrollment>
  <condition>Prostate Cancer</condition>
  <condition>Perioperative Pain</condition>
  <arm_group>
    <arm_group_label>Acu Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>press tack needle acupuncture (ACU) and routine postoperative analgesic care</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SHAM Arm</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>press tack placebo acupressure (SHAM) and routine postoperative analgesic care</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CONTROL Arm</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients in the control group will receive only routine postoperative analgesic care</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Acupuncture</intervention_name>
    <description>On the day before surgery, patients randomized to the intervention groups will receive routine postoperative analgesic care with application of 6 bilateral press tack needles (diameter of 0.15mm and length of 0.6mm for P-6 and Shenmen, diameter of 0.20mm and length of 1.2mm for SP-6, Seirin New Pyonex, Seirin Corp., Shizuoka City, Japan).</description>
    <arm_group_label>Acu Arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Acupressure</intervention_name>
    <description>On the day before surgery, patients randomized to the intervention groups will receive routine postoperative analgesic care with application of 6 bilateral press tack placebos (knob without needle, diameter of 0.15mm and length of 0.6mm for P-6 and Shenmen, diameter of 0.20mm and length of 1.2mm for SP-6, Seirin New Pyonex, Seirin Corp., Shizuoka City, Japan).</description>
    <arm_group_label>SHAM Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males aged 18-70 years

          -  Diagnosis with prostate cancer and scheduled for open radical prostatectomy

          -  Ability and willingness to follow study instructions and complete all required
             questionnaires during hospitalization and follow-up

          -  Written informed consent

        Exclusion Criteria:

          -  Inability to understand the terms of this study

          -  Simultanously participation in other clinical trials possibly influencing primary or
             secondary endpoints or any acupuncture-related clinical trials within 30 days prior to
             inclusion

               -  Prior surgery within the last three months

               -  Received acupuncture within 6 weeks before surgery

               -  Known hypersensitivity or fear of acupuncture

               -  Known abuse of drugs, medications and alcohol

               -  Chronic pain for more than 3 months

               -  Continuous opioid analgesic medications for more than 3 days during the 4 weeks
                  prior to surgery
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Prostate cancer</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hans Heinzer, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vice Medical Director and Faculty member of Martini-Klinik</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anke Renter</last_name>
    <phone>+49(0)741053115</phone>
    <email>a.renter@uke.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Martini-Klinik am UKE GmbH</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Markus Graefen, Professor</last_name>
      <phone>+4904741051300</phone>
      <email>graefen@martini-klinik.de</email>
    </contact>
    <contact_backup>
      <last_name>Anke Renter</last_name>
      <phone>+49047410533115</phone>
      <email>renter@martini-klinik.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>November 13, 2019</study_first_submitted>
  <study_first_submitted_qc>November 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 21, 2019</study_first_posted>
  <last_update_submitted>March 3, 2020</last_update_submitted>
  <last_update_submitted_qc>March 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>prostate cancer</keyword>
  <keyword>pain management</keyword>
  <keyword>acupuncture</keyword>
  <keyword>acupressure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prostatic Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>November 20, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/49/NCT04172649/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

